About ROSEAId

Established in 2020, ROSEAId emerged from a significant collaboration with University of Texas Health, a premier US medical institution. ROSE AI our telepathology platform revolutionizes digital pathology leveraging our AI-driven, cloud-based technology, encompassing academia, research and clinical field requirements.

ROSEAId  the revolutionary platform that broadens the scope and expertise of a pathologist. The platform allows the medical team to collaborate and digitize their footprint ensuring the perpetuity of their skills. Essentially, creating a limitless pathology workspace, allowing pathologists to capture, share, and analyze critical insights in a life-saving manner, regardless of their location.

With state-of-the-art Machine Learning algorithms and our open pretrained Multi-Modal Large Language Model (MMLLM) capabilities we understand complex medical concepts and their interconnections facilitating automation of complex analysis, diagnosis, and construction of various kinds of patient reports. 

We are dedicated to transforming vast data into actionable insights, supporting the evolution of drugs and diagnostics at every stage.

What Makes Us Different

The Values We Live By

Mission

ROSEAId fulfils the specialized requirements of pathologists through the integration of advanced data analytics , streamlined workflow and diagnostics, providing real-time results for improved outcomes.

Vision

Create an unparalleled standard in telepathology for clinical diagnostics, improving patient outcomes, optimizing efficiencies and transforming a new era of medical innovation.

People

Our people's compassion and commitment to achieving better outcomes set them apart, driving a culture of empathy and dedication that fuels our collective pursuit of excellence and impact.

ROSEAId Leaders

Joseph
Rossi

CEO & Board Member

Camille
Beyrouthy, PhD

CFO & Board Member

Dr. Efrat
Eliyahu

Chef Science Officer &
Board Member

Eli
Zukovsky

CTO, Co Founder &
Board Member

Russell
Raff

CPO, Co Founder &
Board Member

Barak
Tsivkin

Board Member

Harvey E.
Rand

Chief Revenue Officer

Baxter
Garcia, PhD

Chief Biomedical Engineer

ROSEAId Science and Medical Advisory Board

Dr. Nirav C. Thosani

University of Texas

Dr. Songlin Zhang

Baylor University

Natasha Shtraizent Frezent

Chef Science Officer

Dr. Yosep Chong The Catholic

University of Korea Medical Director

Dr. Richard Newman

Telespecialists LLC.

Baxter
Garcia, PhD

Chief Biomedical Engineer

ROSEAId Sales Distributors

Farouk Khailann

Senior Market Advisor Middle East, Africa

Paul Cucurullo

STIGroup Limited LLC

Rick Yi

STSC Global Asia

Wendy Cowan

StrongHer Consulting LLC Caribbean, Latin America, Africa

Contact us

Our Offices

New York (Representative)

Houston (Headquarters)

Abu Dhabi (Representative)